• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Death Dis . Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients

tetano

Editor, Senior Moderator
Cell Death Dis


. 2022 Aug 27;13(8):741.
doi: 10.1038/s41419-022-05190-0.
Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients


Sonia André[SUP] #[/SUP][SUP] 1 [/SUP], Marne Azarias da Silva[SUP] #[/SUP][SUP] 1 [/SUP], Morgane Picard[SUP] 1 [/SUP], Aurélie Alleaume-Buteau[SUP] 1 2 [/SUP], Lucy Kundura[SUP] 3 [/SUP], Renaud Cezar[SUP] 3 [/SUP], Calaiselvy Soudaramourty[SUP] 1 [/SUP], Santa Cruz André[SUP] 4 5 6 7 [/SUP], Ana Mendes-Frias[SUP] 6 7 [/SUP], Alexandre Carvalho[SUP] 4 5 6 7 [/SUP], Carlos Capela[SUP] 4 5 6 7 [/SUP], Jorge Pedrosa[SUP] 4 5 [/SUP], António Gil Castro[SUP] 4 5 [/SUP], Paul Loubet[SUP] 8 [/SUP], Albert Sotto[SUP] 8 [/SUP], Laurent Muller[SUP] 9 [/SUP], Jean-Yves Lefrant[SUP] 9 [/SUP], Claire Roger[SUP] 9 [/SUP], Pierre-Géraud Claret[SUP] 10 [/SUP], Sandra Duvnjak[SUP] 11 [/SUP], Tu-Anh Tran[SUP] 12 [/SUP], Ouafa Zghidi-Abouzid[SUP] 13 [/SUP], Pierre Nioche[SUP] 1 2 [/SUP], Ricardo Silvestre[SUP] #[/SUP][SUP] 4 5 [/SUP], Pierre Corbeau[SUP] #[/SUP][SUP] 14 15 [/SUP], Fabrizio Mammano[SUP] #[/SUP][SUP] 16 17 [/SUP], Jérôme Estaquier[SUP] #[/SUP][SUP] 18 19 [/SUP]



Affiliations

Abstract

In addition to an inflammatory reaction, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-infected patients present lymphopenia, which we recently reported as being related to abnormal programmed cell death. As an efficient humoral response requires CD4 T-cell help, we hypothesized that the propensity of CD4 T cells to die may impact the quantity and quality of the humoral response in acutely infected individuals. In addition to specific immunoglobulins (Ig)A, IgM, and IgG against SARS-CoV-2 nucleocapsid (N), membrane (M), and spike (S1) proteins, we assessed the quality of IgG response by measuring the avidity index. Because the S protein represents the main target for neutralization and antibody-dependent cellular cytotoxicity responses, we also analyzed anti-S-specific IgG using S-transfected cells (S-Flow). Our results demonstrated that most COVID-19 patients have a predominant IgA anti-N humoral response during the early phase of infection. This specific humoral response preceded the anti-S1 in time and magnitude. The avidity index of anti-S1 IgG was low in acutely infected individuals compared to convalescent patients. We showed that the percentage of apoptotic CD4 T cells is inversely correlated with the levels of specific IgG antibodies. These lower levels were also correlated positively with plasma levels of CXCL10, a marker of disease severity, and soluble Fas ligand that contributes to T-cell death. Finally, we found lower S-Flow responses in patients with higher CD4 T-cell apoptosis. Altogether, these results demonstrate that individuals with high levels of CD4 T-cell apoptosis and CXCL10 have a poor ability to build an efficient anti-S response. Consequently, preventing CD4 T-cell death might be a strategy for improving humoral response during the acute phase, thereby reducing COVID-19 pathogenicity.
 
Back
Top Bottom